Detalhe da pesquisa
1.
First-Line Osimertinib in Patients with EGFR-Mutant Advanced Non-Small Cell Lung Cancer: Outcome and Safety in the Real World: FLOWER Study.
Oncologist
; 27(2): 87-e115, 2022 03 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35641222
2.
A phase II, open-label, single-arm trial of carboplatin plus etoposide with bevacizumab and atezolizumab in patients with extended-stage small-cell lung cancer (CeLEBrATE study): background, design and rationale.
Future Oncol
; 18(7): 771-779, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-35068173
3.
Immunotherapy in NSCLC Patients with Brain Metastases.
Int J Mol Sci
; 23(13)2022 Jun 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-35806080
4.
Real-world data on treatment outcomes in EGFR-mutant non-small-cell lung cancer patients receiving osimertinib in second or further lines.
Future Oncol
; 17(19): 2513-2527, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33988036
5.
Nivolumab in never-smokers with advanced squamous non-small cell lung cancer: Results from the Italian cohort of an expanded access program.
Tumour Biol
; 40(11): 1010428318815047, 2018 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-30486741
6.
MGMT pyrosequencing-based cut-off methylation level and clinical outcome in patients with glioblastoma multiforme.
Future Oncol
; 14(8): 699-707, 2018 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-29521523
7.
INTEGRATED CARE PATHWAYS IN LUNG CANCER: A QUALITY IMPROVEMENT PROJECT.
Int J Technol Assess Health Care
; 34(1): 3-9, 2018 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-29405098
8.
Drug waste minimization as an effective strategy of cost-containment in oncology.
BMC Health Serv Res
; 14: 57, 2014 Feb 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-24507545
9.
Real-world outcomes of Italian patients with advanced non-squamous lung cancer treated with first-line pembrolizumab plus platinum-pemetrexed.
Eur J Cancer
; 202: 114006, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38489861
10.
Radiation Recall Pneumonitis Anticipates Bilateral Immune-Induced Pneumonitis in Non-Small Cell Lung Cancer.
J Clin Med
; 12(4)2023 Feb 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36835802
11.
The storm of NGS in NSCLC diagnostic-therapeutic pathway: How to sun the real clinical practice.
Crit Rev Oncol Hematol
; 169: 103561, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34856311
12.
EGFR T790M testing through repeated liquid biopsy over time: a real-world multicentric retrospective experience.
J Thorac Dis
; 14(9): 3364-3375, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-36245580
13.
Predictive ability of a drug-based score in patients with advanced non-small-cell lung cancer receiving first-line immunotherapy.
Eur J Cancer
; 150: 224-231, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33934059
14.
Smoking status during first-line immunotherapy and chemotherapy in NSCLC patients: A case-control matched analysis from a large multicenter study.
Thorac Cancer
; 12(6): 880-889, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33527756
15.
Platinum-Based Chemotherapy in Older Patients with Non-Small Cell Lung Cancer: What to Expect in the Real World.
Drugs Aging
; 37(9): 677-689, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32681401
16.
A Multi-Center, Real-Life Experience on Liquid Biopsy Practice for EGFR Testing in Non-Small Cell Lung Cancer (NSCLC) Patients.
Diagnostics (Basel)
; 10(10)2020 09 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-32998450
17.
Immune-related Adverse Events of Pembrolizumab in a Large Real-world Cohort of Patients With NSCLC With a PD-L1 Expression ≥ 50% and Their Relationship With Clinical Outcomes.
Clin Lung Cancer
; 21(6): 498-508.e2, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32680806
18.
Emerging therapies in malignant pleural mesothelioma.
Crit Rev Oncol Hematol
; 144: 102815, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31670225
19.
Third-generation tyrosine kinase inhibitor in the treatment of epidermal growth factor receptor mutated squamous cell lung cancer: a tailored therapy approach.
Ann Transl Med
; 7(1): 14, 2019 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-30788361
20.
Maintenance with lanreotide in small-cell lung cancer expressing somatostatine receptors: A multicenter, randomized, phase 3 trial.
Lung Cancer
; 134: 121-126, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31319970